Home
Search
Study Topics
Glossary
|
|
|
|
|
Sponsored by: |
Schering-Plough |
---|---|
Information provided by: | Schering-Plough |
ClinicalTrials.gov Identifier: | NCT00732368 |
This study examined the safety and effectiveness of long-term administration of mometasone nasal spray in patients with perennial allergic rhinitis.
Patients received mometasone for 12 weeks plus an additional 12 weeks if patient agreed to continue. Dose of mometasone could be decreased or increased during the study based on patient's response.
Condition | Intervention | Phase |
---|---|---|
Perennial Allergic Rhinitis |
Drug: Mometasone furoate |
Phase III |
Study Type: | Interventional |
Study Design: | Treatment, Open Label, Uncontrolled, Single Group Assignment, Safety/Efficacy Study |
Official Title: | A Long-Term Study of Mometasone Furoate in Patients With Perennial Allergic Rhinitis |
Enrollment: | 98 |
Study Start Date: | May 2005 |
Study Completion Date: | January 2006 |
Primary Completion Date: | January 2006 (Final data collection date for primary outcome measure) |
Arms | Assigned Interventions |
---|---|
Mometasone Nasal Spray: Experimental
Open-label. Two sprays per nostril once daily (200 mcg/day). After 4 weeks, dose can be decreased to one spray per nostril daily or increased to 4 sprays per nostril daily.
|
Drug: Mometasone furoate
Two sprays mometasone nasal spray per nostril once daily (200 mcg/day). After 4 weeks, dose can be decreased to one spray per nostril daily or increased to 4 sprays per nostril daily.
|
Ages Eligible for Study: | 16 Years and older |
Genders Eligible for Study: | Both |
Accepts Healthy Volunteers: | No |
Inclusion Criteria:
Exclusion Criteria:
Responsible Party: | Schering-Plough ( Head, Clinical Trials Registry & Results Disclosure Group ) |
Study ID Numbers: | P04459 |
Study First Received: | August 8, 2008 |
Last Updated: | October 23, 2008 |
ClinicalTrials.gov Identifier: | NCT00732368 History of Changes |
Health Authority: | Japan: Pharmaceuticals and Medical Devices Agency |
Anti-Inflammatory Agents Hypersensitivity Otorhinolaryngologic Diseases Respiratory Tract Infections Respiratory Tract Diseases Rhinitis, Allergic, Perennial |
Mometasone furoate Hypersensitivity, Immediate Rhinitis Anti-Allergic Agents Respiratory Hypersensitivity |
Anti-Inflammatory Agents Otorhinolaryngologic Diseases Immune System Diseases Mometasone furoate Rhinitis Anti-Allergic Agents Pharmacologic Actions Nose Diseases |
Hypersensitivity Rhinitis, Allergic, Perennial Respiratory Tract Diseases Respiratory Tract Infections Therapeutic Uses Hypersensitivity, Immediate Respiratory Hypersensitivity |